ID
41731
Beskrivning
Study ID: 111582 Clinical Study ID: 111582 Study Title: An Open Label Study to Examine the Effects of Low-fat and High-fat Meals on the Pharmacokinetics of Orally Administered Lapatinib in Metastatic ErbB2 Positive Breast Cancer Patients. Patient Level Data: Study Listed on ClinicalStudyDataRequest.com Clinicaltrials.gov Identifier: NCT00821054 https://clinicaltrials.gov/ct2/show/NCT00821054 Sponsor: GlaxoSmithKline Collaborators: N/A Phase: Phase 1 Study Recruitment Status: Completed Generic Name: Lapatinib Trade Name: N/A Study Indication: Neoplasms, Breast The study consists of a screening, four study visits at day-1, week 1, 2 and 3 and a follow-up visit. This document documents any repeating Pharmacokinetics Blood measurements.
Länk
https://clinicaltrials.gov/ct2/show/NCT00821054
Nyckelord
Versioner (1)
- 2021-01-09 2021-01-09 -
Rättsinnehavare
GlaxoSmithKline
Uppladdad den
9 januari 2021
DOI
För en begäran logga in.
Licens
Creative Commons BY-NC 4.0
Modellkommentarer :
Här kan du kommentera modellen. Med hjälp av pratbubblor i Item-grupperna och Item kan du lägga in specifika kommentarer.
Itemgroup-kommentar för :
Item-kommentar för :
Du måste vara inloggad för att kunna ladda ner formulär. Var vänlig logga in eller registrera dig utan kostnad.
Effects of Low-fat and high-fat meals on the Pharmacokinetics of Lapatinib in ErB2+ Breast Cancer patients, NCT00821054
Similar models
Pharmacokinetics Repeat
- StudyEvent: ODM
C0005767 (UMLS CUI-2)
C0205341 (UMLS CUI-3)
C2348184 (UMLS CUI [1,2])
C0439230 (UMLS CUI [1,2])
C0237753 (UMLS CUI [1,3])
C1264639 (UMLS CUI [1,2])